Drugplain

Simponi 50 mg/.5mL

golimumab · INJECTION, SOLUTION · Janssen Biotech, Inc.

No Recall History
Plain English

Simponi is a injection, solution containing golimumab at 50 mg/.5mL, taken subcutaneous. Manufactured by Janssen Biotech, Inc..

Key Facts

Brand Name
Simponi
Generic Name
golimumab
NDC Code (Product)
57894-070
Manufacturer
Janssen Biotech, Inc.
Strength
50 mg/.5mL
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Marketing Status
Application #
BLA125289
Drug Class
Tumor Necrosis Factor Blocker [EPC]
Marketing Start
04/25/2009

Recall History

No Recall History

Frequently Asked Questions

What is Simponi used for?

Simponi contains golimumab. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.

Is Simponi a controlled substance?

Simponi is not classified as a controlled substance by the DEA.

What is the generic name for Simponi?

The generic name for Simponi is golimumab. There are 1 other brand versions of golimumab.

What is the NDC code for Simponi 50 mg/.5mL?

The NDC (National Drug Code) for Simponi 50 mg/.5mL is 57894-070, listed by Janssen Biotech, Inc..

Product NDC

57894-070

Package NDC

57894-070-01

Other Simponi Dosages

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)